Octrode
Payments companies reported to CMS as associated with Octrode. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Octrode, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Octrode
These are the largest totals companies reported as associated with Octrode. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rudy Garza | Round Rock, TX | Interventional Pain Medicine | $4,363.92 |
| Clayton Adams | Austin, TX | Interventional Pain Medicine | $4,297.61 |
| Allen Dennis | Georgetown, TX | Interventional Pain Medicine | $3,799.64 |
| Ryan Jacobs | Killeen, TX | Pain Medicine (Physical Medicine & Rehabilitation) | $3,628.30 |
| Kristin Jarzombek | Kyle, TX | Interventional Pain Medicine | $3,592.86 |
| Adam Spjute | Waco, TX | Interventional Pain Medicine | $3,481.74 |
| Bradley Culling | Killeen, TX | Interventional Pain Medicine | $3,379.89 |
| Mark Malone | Round Rock, TX | Interventional Pain Medicine | $3,377.55 |
| Matthew Hellman | Kyle, TX | Interventional Pain Medicine | $3,273.25 |
| Jeffrey Higginbotham | Austin, TX | Interventional Pain Medicine | $2,892.00 |
Prescribed Octrode?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.